Bahala, Charlize Gilliane .

HRN: 24-29-25  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2024
CO-AMOXICLAV 625MG (TAB)
01/04/2024
01/09/2024
PO
1 Tab
BID
Perineal Swelling
Waiting Final Action 
01/04/2024
CO-AMOXICLAV 625MG (TAB)
01/04/2024
01/09/2024
PO
1 Tab
BID
Perineal Swelling
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: